Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jadesola Abdurrahman"'
Autor:
Oluwafemi Adeleke Ojo, Temiloluwa Rhoda Adeyemo, Matthew Iyobhebhe, Moses Dele Adams, Rotdelmwa Maimako Asaleye, Ikponmwosa Owen Evbuomwan, Jadesola Abdurrahman, Tobiloba Christiana Maduakolam-Aniobi, Charles Obiora Nwonuma, Olalekan Elijah Odesanmi, Adebola Busola Ojo
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-21 (2024)
Abstract Beta vulgaris L. is a root vegetable that is consumed mainly as a food additive. This study aimed to describe the protective effect of B. vulgaris on Fe2+-mediated oxidative liver damage through in vitro, ex vivo, and in silico studies to es
Externí odkaz:
https://doaj.org/article/b864d67b2f6b46daa796a7758b61b8c5
Autor:
Oluwafemi Adeleke Ojo, Adebola Busola Ojo, Charles Okolie, Jadesola Abdurrahman, Morayo Barnabas, Ikponmwosa Owen Evbuomwan, Oluwabori Paul Atunwa, Bukola Atunwa, Matthew Iyobhebhe, Tobiloba Christiana Elebiyo, Charles Obiora Nwonuma, Abayomi Emmanuel Adegboyega, Safaa Qusti, Eida M. Alshammari, Helal F. Hetta, Gaber El Saber Batiha
Publikováno v:
Informatics in Medicine Unlocked, Vol 26, Iss , Pp 100720- (2021)
Type-2 diabetes mellitus (T2DM), is considered being a multifaceted disorder that presents a major therapeutic problem. Despite the widespread efforts in managing T2DM, drug discovery therapies remain insufficient. There are several new and vital ant
Externí odkaz:
https://doaj.org/article/6e0a374d087a4d0f8d145c63b0d8046f
Autor:
Jadesola Abdurrahman, Oluwabori Paul Atunwa, Matthew Iyobhebhe, Charles Obiora Nwonuma, Morayo Barnabas, Oluwafemi Adeleke Ojo, Bukola Atunwa, Helal F Hetta, Charles E. Okolie, Abayomi Emmanuel Adegboyega, Eida M. Alshammari, Tobiloba Christiana Elebiyo, Safaa Y. Qusti, Ikponmwosa Owen Evbuomwan, Gaber El-Saber Batiha, Adebola Busola Ojo
Publikováno v:
Informatics in Medicine Unlocked, Vol 26, Iss, Pp 100720-(2021)
Type-2 diabetes mellitus (T2DM), is considered being a multifaceted disorder that presents a major therapeutic problem. Despite the widespread efforts in managing T2DM, drug discovery therapies remain insufficient. There are several new and vital ant